Status:
COMPLETED
Studies of Human Herpesvirus 8 and Kaposi's Sarcoma in Sicily
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Kaposi s Sarcoma (KS)
Eligibility:
All Genders
18-99 years
Brief Summary
A series of studies will be conducted in Sicily by a collaborative team from the U.S. National Cancer Institute and the University of Palermo to better understand the prevalence and risk factors for t...
Detailed Description
A series of studies will be conducted in Sicily by a collaborative team from the U.S. National Cancer Institute and the University of Palermo to better understand the prevalence and risk factors for t...
Eligibility Criteria
Inclusion
- Pool of HHV8 seropositive controls.
Exclusion
Key Trial Info
Start Date :
July 30 1998
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 6 2020
Estimated Enrollment :
4622 Patients enrolled
Trial Details
Trial ID
NCT00339937
Start Date
July 30 1998
End Date
May 6 2020
Last Update
March 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universita Degli Studi Di Palermo
Palermo, Italy